ACHC — Acadia Healthcare Company, Inc.
Is ACHC overbought or oversold? Here is the current MarketMoodz read.
Acadia Healthcare Company, Inc. (ACHC) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Healthcare name (Medical Care Facilities) last closed at $37.94. The rating moved from Neutral to Overbought on November 12, 2026.
- Public ratingOverbought (as of November 17, 2026)
- Last close$37.94
- Last changeMoved from Neutral to Overbought on November 12, 2026
- SectorHealthcare
- IndustryMedical Care Facilities
See all overbought Healthcare stocks →
AI analysis
Acadia Healthcare operates a broad, national behavioral health platform with steady demand drivers and recurring inpatient/outpatient cash flows. Scale and a track record of strategic acquisitions support growth and capital efficiency, while demographic and access trends offer a favorable long-term addressable market. Near-term performance is sensitive to reimbursement dynamics, rising labor costs and regulatory actions that could increase compliance burdens or result in payer clawbacks. With no major market or geopolitical shock in the immediate window, the stock may see measured upside as earnings cadence and integration execution confirm growth; however, sustaining margin expansion depends on payor negotiations, occupancy levels and operational leverage.
Key factors
- Sustained secular demand for behavioral health and addiction treatment services supports utilization and revenue visibility
- Large national footprint and diversified mix of inpatient, outpatient and specialty services provides scale advantages and referral network benefits
- History of disciplined M&A and integration to expand capacity and accelerate revenue growth potential
- Relatively stable cash flows from inpatient/residential operations that can support debt service and capital investment
- Favorable demographic and mental-health access trends that underpin long-term addressable market growth
- Current market environment is neutral-consolidative, limiting downside from macro shocks in the near term
Risks
- Regulatory and reimbursement pressure (including CMS proposals affecting Medicare Advantage integrity and clawbacks) that could compress revenue per admission or increase compliance costs
- High exposure to public payors (Medicaid/Medicare) and contract negotiation risk with commercial insurers and MA plans
- Staffing shortages and rising labor costs that can erode operating margins and constrain capacity
- Integration and execution risk from acquisitions; earnings quality may be affected if acquisitions underperform
- Occupancy volatility driven by local demand cycles, competitor capacity or policy changes that limit admissions
- Legal, licensing or quality-of-care litigation and regulatory enforcement that can result in fines, remediation costs or reputational damage
See today's live rating, score and targets
Members see the live hourly rating for ACHC — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.